Document Detail


Recurrence of hepatitis-associated aplastic anemia after a 10-year interval.
MedLine Citation:
PMID:  18827426     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatitis-associated aplastic anemia (HAA) has been reported to show a successful outcome following immunosuppressive treatment. On the other hand, the long-term prognosis of HAA has not been sufficiently clarified. Herein we report a patient with HAA who had been treated with cyclosporine for one year, and maintained complete remission without treatment. Ten years later, acute non-A, non-B, and non-C hepatitis reccurred followed by bone marrow aplasia. A second immunosuppressive treatment with antithymocyte globulin and cyclosporine was effective. This case might provide useful information for the long-term follow-up of patients with HAA.
Authors:
Tsuyoshi Muta; Yoshinori Tanaka; Eiji Takeshita; Yuichi Kobayashi; Takahito Tokuyama; Yoko Ueda; Koji Joko; Tomoaki Fujisaki; Eisuke Yokota
Related Documents :
1860266 - Treatment of adult idiopathic nephrotic syndrome with cyclosporin a: minimal-change dis...
20466116 - Steroid use after the kasai procedure for biliary atresia.
24500916 - The prevalence of rotator cuff tears: is the contralateral shoulder at risk?
23843056 - Anthropometric measurements as an indicator of nutritional status in spina bifida patie...
24333196 - Long-term outcomes of direct and indirect below-the-knee open revascularization based o...
639566 - Mohs' chemosurgery for the treatment of cutaneous gangrene.
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2008-10-01
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  47     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2008  
Date Detail:
Created Date:  2008-10-01     Completed Date:  2009-01-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1733-7     Citation Subset:  IM    
Affiliation:
Department of Hematology, Matsuyama Red Cross Hospital. muta-t@matsuyama.jrc.or.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anemia, Aplastic / complications*,  drug therapy,  pathology
Antilymphocyte Serum / therapeutic use
Cyclosporine / therapeutic use
Hepatitis / drug therapy,  etiology*,  pathology
Humans
Immunosuppressive Agents / therapeutic use
Male
Methylprednisolone / therapeutic use
Recurrence
Time Factors
Chemical
Reg. No./Substance:
0/Antilymphocyte Serum; 0/Immunosuppressive Agents; 59865-13-3/Cyclosporine; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mycobacterium avium pleuritis in a non-immunocompromised patient.
Next Document:  Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer.